Po-Yi Ho, Ph.D., MSc

Po-Yi Ho, Ph.D., MSc has a comprehensive work experience in the field of biosciences. They started their career as a Research Scientist at the Georgia Institute of Technology, where they conducted various research projects related to breast cancer, hyaluronan, and embryonic development. They also collaborated with a synthetic chemistry group in validating potential inhibitors for histone lysine demethylase.

Dr. Ho then joined the Centers for Disease Control and Prevention as an ORISE Fellow, where they played a significant role in investigating and studying hepatitis A and C outbreaks. They were responsible for utilizing Next-Generation Sequencing (NGS) and Sanger sequencing techniques in their research.

After their time at the CDC, Dr. Ho contributed their expertise to Flexion Therapeutics as a Scientist in both Process and Analytical R&D for Biologics, as well as Analytical Development. At Flexion Therapeutics, they worked on developing processes and analytical methods for biologic products.

More recently, Dr. Ho joined Ensoma as a Scientist II in Analytical Development before transitioning to their current position as a Senior Scientist in Analytical Development at Carbon Biosciences.

Overall, Dr. Ho's work experience demonstrates their expertise in analytical development and research, particularly in the areas of genetics, cancer, and infectious diseases.

Po-Yi Ho, Ph.D., MSc pursued a Doctor of Philosophy (PhD) degree in Molecular and Cell Biology from the Georgia Institute of Technology. Prior to that, they completed a Master of Science (M.S.) degree in Genetics from National Yang Ming University.